Break Up with Your Makeup

Disclosure: This post was sponsored by Galderma Laboratories L.P. through their partnership with POPSUGAR. While I was compensated by POPSUGAR to write a post about Mirvaso, all opinions are my own.

Galderma Mirvaso Break Up with your makeup

I’ve never been shy with you about my struggles with rosacea. I’m one of an estimated 16 million who deal with this skin condition everyday. And facial redness is by far one of the biggest symptoms I face when I look in the mirror.

In addition to transparency about my rosacea and skin problems, I’ve also admitted that I have relied on makeup to get me through flare-ups, and to help me me feel confident. Data shows that I’m not alone; 77 percent of rosacea sufferers wear makeup compared with 53 percent of those who don’t have the skin condition.

But instead of always using makeup to conceal the redness, there is a treatment option, like Mirvaso, the only FDA-approved treatment for the persistent redness of rosacea. Mirvaso works fast, providing same-day results that last up to 12 hours before the redness returns, leaving users red-carpet ready!

Galderma Mirvaso Break Up with your makeup

And speaking of red carpet ready, Galderma, the brand behind Mirvaso, is hosting a sweepstakes to raise awareness of the treatment and to encourage people like me to “Break Up with Your Makeup.” You can enter here, and also learn more about rosacea and Mirvaso as a treatment.

Important Safety Information
Indication:  Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.  Adverse Events:  In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis.  Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.